Arcutis Biotherapeutics, Inc. (ARQT)
27.45
+1.25
(+4.77%)
USD |
NASDAQ |
Nov 10, 16:00
27.45
0.00 (0.00%)
After-Hours: 20:00
Arcutis Biotherapeutics Cash from Operations (Annual) : -5.625M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -5.625M |
| December 31, 2024 | -112.16M |
| December 31, 2023 | -247.06M |
| December 31, 2022 | -257.72M |
| December 31, 2021 | -174.63M |
| Date | Value |
|---|---|
| December 31, 2020 | -113.03M |
| December 31, 2019 | -44.24M |
| December 31, 2018 | -14.08M |
| December 31, 2017 | -3.775M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| ADMA Biologics, Inc. | 50.40M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |
| Anika Therapeutics, Inc. | 11.19M |
| Savara, Inc. | -101.04M |